Commonwealth Financial Services LLC Takes $212,000 Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Commonwealth Financial Services LLC acquired a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 357 shares of the biotechnology company’s stock, valued at approximately $212,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Asset Dedication LLC increased its position in shares of Axon Enterprise by 11.3% during the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after acquiring an additional 18 shares during the last quarter. Insigneo Advisory Services LLC boosted its position in shares of Axon Enterprise by 1.4% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after purchasing an additional 22 shares during the period. Menard Financial Group LLC increased its holdings in Axon Enterprise by 0.8% in the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after purchasing an additional 24 shares during the last quarter. PFG Investments LLC increased its holdings in Axon Enterprise by 0.6% in the 3rd quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock valued at $1,547,000 after purchasing an additional 25 shares during the last quarter. Finally, Gladstone Institutional Advisory LLC raised its position in Axon Enterprise by 1.6% in the third quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock valued at $656,000 after purchasing an additional 26 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Needham & Company LLC lifted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Robert W. Baird raised their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. TD Cowen started coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective for the company. Finally, Northland Securities boosted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $524.85.

Insiders Place Their Bets

In related news, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the transaction, the insider now owns 154,394 shares in the company, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the transaction, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. The trade was a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 50,545 shares of company stock valued at $30,721,337. 5.70% of the stock is owned by corporate insiders.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $658.11 on Tuesday. The stock’s 50-day simple moving average is $620.41 and its 200-day simple moving average is $486.16. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm has a market capitalization of $50.18 billion, a PE ratio of 170.05, a price-to-earnings-growth ratio of 6.54 and a beta of 1.05. Axon Enterprise, Inc. has a fifty-two week low of $252.20 and a fifty-two week high of $698.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.